Question 32 1 out of 1 points A male patient is receiving heparin by continuous intravenous infusion. The nurse will instruct the patient and family members to report which of the following should it occur? Selected
Answer: A. Presence of blood in urine or stools Correct Answer: A. Presence of blood in urine or stools Response Feedback : The nurse should instruct the patient and family members to report the presence of blood in urine or stools and any bleeding from the gums, nose, vagina, or wounds. The anticoagulation properties of heparin can sometimes result in abnormal bleeding. Sleepiness, drowsiness, skin rash, and dizziness are not commonly identified adverse effects of the drug. Question 33 1 out of 1 points A patient with a recent diagnosis of chronic myelogenous leukemia (CML) is discussing treatment options with his care team. What aspect of the patient's condition would contraindicate the use of cyclophosphamide for the treatment of leukemia? Selected Answer: A. The patient's bone marrow function is significantly depressed. Correct Answer: A. The patient's bone marrow function is significantly depressed. Response Patients with severely compromised bone marrow functions Feedback : cannot tolerate treatment with cyclophosphamide. Diabetes, impaired renal function, and previous nonadherence to treatment must be addressed when planning the patient's care, but these factors do not necessarily contraindicate the use of cyclophosphamide. Question 34 0 out of 1 points A 60-year-old patient experienced a sudden onset of chest pain and shortness of breath and was subsequently diagnosed with a pulmonary embolism in the emergency department. The patient has been started on an intravenous heparin infusion. How does this drug achieve therapeutic effect? Selected Answer: B. By inhibiting platelet aggregation on vessel walls and promoting fibrinolysis Correct Answer: D. By inactivating clotting factors and thus stopping the
coagulation cascade Response Feedback: Heparin, along with antithrombin, rapidly promotes the inactivation of factor X, which, in turn, prevents the conversion of prothrombin to thrombin. Heparin does not achieve its therapeutic effect through the excretion or inhibition of vitamin K or by inhibiting platelet aggregation. Question 35 0 out of 1 points A nurse has been assigned to a female patient who is to begin chemotherapy. The nurse will initiate the prescribed oprelvekin therapy Selected Answer: D. 6 days after chemotherapy. Correct Answer: C. 6 to 24 hours after chemotherapy. Response Feedback: Administration of oprelvekin should begin 6 to 24 hours after the end of chemotherapy. Oprelvekin should be discontinued at least 2 days before the next chemotherapy session begins.
- Fall '13
- Oncology, Chemotherapy, Leukemia, Rituximab